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Abstract
E. coli is considered one of the best model organism for biopharmaceutical
production by fermentation. Its utility in process development is employed to
develop various vaccines, metabolites, biofuels, antibiotics and synthetic molecules in
large amounts based on the amount of yield in shake flasks, bioreactors utilised by
batch, fed-batch and continuous mode. Production of the desired molecule is facili-
tated in the bioreactor by employing strategies to increase biomass and optimised
yield. The fermentation is a controlled process utilising media buffers, micronutrients
and macronutrients, which is not available in a shake flask. To maximise the produc-
tion temperature, dissolved oxygen (aerobic), dissolved nitrogen (anaerobic),
inducer concentration, feed or supplementation of nutrients is the key to achieving
exponential growth rate and biomass. Design of experiments (DOE) is critical for
attaining maximum gain, in cost-effective manner. DOE comprises of several strate-
gies likewise Plakett-Burman., Box–Behnken, Artificial Neural Network, combination
of these strategies leads to reduction of cost of production by 2–8 times depending
on molecules to be produced. Further minimising downstream process for quickly
isolation, purification and enrichment of the final product.
Keywords: E. coli, Design of experiments (DOE), Response surface methodology,
Bacterial Fermentation, Batch, Fed-batch, Process optimisation, glycosylation,
disulfide bridges, codon optimisation, host, post-translational modifications,
inclusion bodies
1. Introduction
E. coli is most studied bacteria learned of symbiotic relationships with human for
years derived after culturing F Plasmid of a 1922 isolate from a diptheria patient.
Production of biopharmaceuticals from E. coli is in practice since 1965. Also, the it
served for production of biopharmaceuticals such as recombinant proteins, metab-
olites by several companies namely BPB Bioscience, Agilent technologies, Promega,
Takara, Tonbo Biosciences, New England Biolabs, Novagen and Lucigen. They are
optimised for expression of challenging proteins difficult to express, purify and
folding in native conformation. Moreover, formation of proper disulphide bonds
and refolding of membrane proteins is also achieved by using newly commercially
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available strains. These strains are suitable for production of metabolites and
enzymes in easy to scale-up process development. The cultivation of E. coli is
facilitated by optimisation of concentrations of tryptone (plant and animal
derived), yeast extract, casamino acids. These are divided in three categories car-
bon, nitrogen and micronutrients, as per sustainable development goals set by
united nations for 2030. Innovation for increasing productivity using technology is
one of the 17 subject areas, it is need to follow typical strategy, which is usually
unique for production of an active compound or protein. The Table 1, below
describes different strategies to discovered for optimisation of product by utilising
model organism E. coli (Table 1) [57].
Production of Biopharmaceuticals and Biomolecules during fermentation
require media formulated using cheap ingredients for supplementation of carbon
and nitrogen. The carbon sources are typically glucose, glycerol, molasses
(Table 1). Nitrogen sources are typically yeast extract and digested proteins by
enzymes. The utilisation of carbon by E. coli during batch can be inhibited due to
accumulation of acetate, formate and succinate. Historically several attempts have
been made to design defined or semi-defined media recipes that do not require bio
nutrient additives. Traditionally, media developed generally utilise one-factor-at-a-
time (OFAT) where all but one ingredient (factor) is fixed [58, 59]. This approach
guides towards determining individual factors that influence culture growth. Effect
of utilisation of amino acids, vitamins and minerals interaction are not possible
using OFAT. These interactions can be studied using DoE and multifactorial
designs.
DoE is a multifactorial methodology utilising statistical approaches to design and
analyse an experimental process by which better outcome and results are obtained.
Bacterial growth is the system response impact of “DoE planning” by varying
critical parameters and simultaneous factors, such as phosphate, sulphate, vitamin
and amino acid concentrations. The full factorial design, DoE is attributed by
important principals to allow for robust, valid experimentation. These are known as
treatments, replicated, randomised to protect against hidden factors [59]. All treat-
ments must be performed in blocks to control sources of variation. In an experi-
mental process design, all four principles, the statistical approach, conform to
regulations and complete exploration of an extensive experimental design process,
helps in reducing the number of experiments to get a good outcome [60]. For
cultivation using E. coli, statistically relevant experimental designs for industrially
important proteins (rB-glucosidase, human superoxide dismutase) is studied. A
similar approach is applied enzymes, recombinant antibodies and therapeutic pro-
teins(Ranibizumab, Somatropin Certolizumab pegol, PEG interferon alfa-2b,
Romiplostim, Interferon-beta 1b, Pegloticase, etc.) [61]. The optimisation of media
and critical components is needed for E. coli fermentation in batch and fed-batch
fermentation is required to achieve a better growth rate, target product per litre of
fermentation and reduced cost of production. The cost of various fermentation
ingredients for one batch size 10 L of fermentation ranges from 20 to 155 USD
(Table 2). The cost of media ingredients reduces after scaling up of process for
production from 15 to 5000 L.
The DoE with a correct statistical model to understand the effect is needed to be
adopted by industrial producers to achieve a robust and high yielding process. The
DOE is statistically planned trials for optimising factors associated with increased
product output, yield and cost reduction. Typically, DOE experiments are done to
screen up to 2–15 elements. Traditionally, using OFAT, the number of experiments
needed to determine the effect on yield, the output is numerous. Using the DOE
approach, several components, additives and sources of nutrients are compared
2
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simultaneously, and their impact is evaluated. Based on the response critical factors
are ranked. Soon after the response effect by variables are generated, the analysis is
successively recorded. Various DoE experiments are studied to understand
influencing factors determined by a statistically relevant experimental plan. The
difference in factors is measured by Analysis of variance (ANOVA). The results
obtained after analysing responses are plotted using contour plots and response
surface methodology (RSM). There are several software packages for optimisation
of critical factors and parameters Design Expert (Stat-Ease Inc.), GT-SUITE (DOE),
DOE ++ (RecCom), MODDE (Umetrics), DoE Fusion PRO (S-Matrix Corp.),
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Table 1.
Strategies and optimization parameters and type of fermentation in production of various proteins and small
molecules.
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2. Critical fermentation ingredients
Critical fermentation ingredients are media components which cannot be
replaced. These can only be standardised for maximised yield. Typically, buffers
and nitrogen sources such as yeast extract, tryptone are not changed. Since E. coli is
the most studied and highly utilised systems for producing various enzymes, anti-
bodies, and biological products. Bacteria require specific conditions for growth
attributed to factors such as oxygen, pH, temperature, and light. Bacterial growth is
divided into lag, exponential (log) and stationary phase. During the initial stage,
cellular activity in a rich nutrient medium allows cells to synthesise proteins, cells
increase in size, but no cell division occurs in the phase. During the exponential
phase, metabolic activity is high as DNA, RNA, cell wall components, or machinery
needed for division are generated. The stationary phase is triggered due to the
accumulation of waste products and depletion of nutrients. During the late log
phase, proteins are induced by the addition of allolactose analogue, Isopropyl β-D-1-
thiogalactopyranoside (IPTG) [63, 64]. The expression of recombinant products is
controlled by promoter systems like T5 and T7 RNA Polymerases. Alternative
promoter systems, such as auto-inducible phoA promoter system [13], the salt-
inducible promoter (proU), arabinose-inducible promoter (pBAD) [65], the heat-
inducible phage Lamba promoters (pL and pR), the cumate-inducible T5 promoter-
based system [66], and the cold-inducible cspA promoter-based system [67] are
also valuable for the biologics production. The cost of biologics production is due to
the high cost of raw material and fermentation media. In the biologics industry, the
more straightforward, cheaper, and reproducible process is highly appreciated.










NH4Cl 7 7 28 71
KH2PO4 1.5 7.5 0 22
Na2HPO4 1.5 7.5 0 18
K2SO4 0.35 0.85 0 1
MgSO4.7 H2O 0.17 0.17 0.86 0
Trace Elementsa 0.8 0.8 3.2 1
Yeast extract 5 10 15 12
Glucose 0
Batch 1.0–5.0 20 27
Fed-Batch 1 99 1
Glycerol 0
Batch 1.0–3.0 1
Fed-Batch 2 30–60 1
Total Cost 155b
Amount of component added to the medium listed for purpose mentioned (g/L).
aMillilitres of trace elements solution, prepared as described added as 1X to medium or feed solution.
bCost of media components calculated with consumption in fermentation using high grade reagents.
Table 2.
Components of media used to grow E. coli in batch and fed-batch fermentations.
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Fermentation media is a critical component, and a balance of nutrients is needed for
increasing productivity. Standardisation of E. coli fermentation requires identifying
a combination of various media components available, e.g., Yeast extract, Soyabean
meal, Bactotryptone, Meat extract and Enzymatic digest of plant and animal protein
(Trypic or casein enzymes). There are various carbon sources (glucose, glycerol,
sucrose, lactose etc). Additives for fermentation are vitamins, amino acids, and
trace elements. Designing a media needs to evaluate the requirement of each of the
individual component along with the additives. The design of model using statistical
approach having multiple parameters in consideration, followed by validation of
defined parameters using fermentation. This is achieved using DoE experimenta-
tion (Figure 1). Experiments are carried out at Shake flash level with selected
nutrients such as carbon and nitrogen sources. Small scale studies are carried out to
define as batch or fed-batch fermentation. Next stage is to screen the components
available for fermentation of batch/fed batch. Once the components are finalised
the possibility of Scale-up is evaluated based on the availability from the source.
Finalisation of media components is carried out using shake flask with DOE of
media buffer additives and inducers. Evaluation of various product outcome bio-
mass ratio and validation of protein quality is also study with 3 to 5 selected designs.
Once the nutrient and components are finalised pilot scale batches setup to study
biomass to product ratio. Further optimisation of dissolved oxygen and temperature
in fermentation is carried out by the DOE approach. If results are not reproducible
with the selected condition, other near possible designs are studied to finalise the
medium and process for fermentation (Figure 1). The process of selection of com-
ponents is based on outcome in an experiment calculated by Biomass (OD), product
output g L1 and cost of ingredients. The process is clearly defined in (Figure 1).
2.1 Batch fermentation
In microbial batch, fermentation cultivation is done in a fixed volume of
medium in a fermenter. The standard inoculum in the fermenter is 50–200 mL of
shake flask volume in 2–5 L of fermentation media. The batch fermentation
Figure 1.
Flow diagram for logical designing of upstream process for fermentation for E. coli. Legend: Y = yes, N = No.
8
Fermentation - Processes, Benefits and Risks
typically OD600 is 20–40 in 8–12 h time. The microbial growth depletes the nutri-
ents resulting in the accumulation of by-products; there is a continuous change in
the culture environment. After completion of the batch, media and cells are
harvested. The advantages are batch fermentation, ease of operation, low risk of
contamination, high yield of protein to biomass in less time of fermentation, and
majorly for soluble or excreted proteins. Typical disadvantages are relatively long
downtime between batches due to vessel setup and sterilisation, low cell/biomass
densities, due to cleaning. DOE is needed to optimise the required nutrients and
minimise product accumulation during fermentation. Typical batch fermentation
media constitutes Yeast extract, Bactotyptone (or Soybean meal) 10 g l to 24 g l,
respectively. Buffers of Sodium and potassium phosphate in combination to reach
pH 6.8. to 7.0, 100 X amino acid solution, Trace elements (400x) is CoCl2. 6H2O
(1 mg/ml1), MnCl2.4H2O (6 mg ml
1), CuCl2.2H2O (0.6 mg ml
1), H3BO3
(1.2 mg ml1), Na2MoO4.2H2O(1 mg ml
1), Zn(II)acetate.2H2O (5.2 mg ml
1) and
Fe(III)citrate (40 mg ml1) [54]. The typical medium components are listed in the
(Table 2) for batch fermentation as a base design to start optimisation.
2.2 Fed-batch fermentation
Fed-batch fermentation is a standard mode of fermentation in the bioprocess
industry. Typically, fed-batch fermentation starts at the end of batch fermentation.
E. coli is adapted and cultivated in defined media. In Fed-batch fermentation, cells
are inoculated and grown in batch mode for 10–15 h. Once all the nutrients are
depleted, evident by analysing the amount of glucose in the medium, dissolved
oxygen levels are increased to 60–80%. The Fed-batch fermentation is initiated by
starting to feed of Glucose, Vitamins, amino acids, and trace elements. The feed is
added to the medium to allow the volumetric cell to increase the mass concentration
exponentially. The growth rate of is changed to 0.12–0.22 μ h1 during fed batch
stage. These equations determine the growth rate in the medium.
ms ið Þ ¼ setþmYX=Sð ÞVSo, (1)
ms tð Þ ¼ ms ið Þeset ∗ t tið Þ (2)
The first equation, ms (i), is the value of feed rate at the initiation of the fed-
batch phase at time ti. μset is the specific growth rate, m is specific maintenance
coefficient, YX/S is yield coefficient, V is the bioreactor volume, and So is the initial
glucose concentration. In the second equation, ms(t) is the rate of addition of
substrate (g h1). After induction of protein expression, the specific growth rate of
E. coli is typically reduced to 0.1 μ h1. The cells are harvested after completion of
the run. Suppose the growth rate is not specified during fermentation, constant
accumulation of several toxic metabolites produced during the fed-batch process
acetate, formate, succinate, and lactate, resulting in oxygen limitation fed-batch.
Therefore, it is recommended to wash cells with Tris-EDTA buffers after washing
E. coli cells are stored or lysed for downstream processing. The distinct advantage of
resuspending E. coli after completion of batch reduces protein degradation due to
metalloproteases [46].
Start of feed is determined by measuring the concentration of substrate in the
fermentation broth typically after 10–12 hrs of batch. The feeding strategy should
be designed so that the growth rate is maintained to limit the production of toxic
formate, acetate and other metabolic compounds, enhancing bacterial growth. The
growth of bacteria and conversion of feed to biomass is maximum when the
exponential growth phase is maintained. The utility of fed-batch and importance is
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obtaining high cell density and biomass, leading to increased production of the high
amount of product yield. The fed-batch is applicable to increase product yield by
limiting growth rate and controlled substrate utilisation (Table 2). The media for
batch and fed-batch fermentation is listed (Table 2).
3. Culture nutrient optimization strategies
3.1 One factor at a time- classical media optimisation methods
Selection of one-factor-at-a-time (OFAT) is a traditional method for optimisa-
tion of media. In this strategy only one factor is varied keeping all other parameters
constant. The usual choice is ease and convenience; it makes OFAT the most pre-
ferred choice for formulating, designing, optimising, and scaling up the fermenta-
tion medium [68]. This method is still popular among many research groups for
developing the medium for fermentation. Physical parameters, supplementation,
removal, replacement and feedback experiments are primary considerations during
OFAT. They comprise of growth temperature, operating pressure, size of nutrients
or extracts. The bioprocess in fermentation controls constant supply of nutrients,
removing metabolic products and toxic compounds, and constantly disseminating
the nutrient solids, buffers and salts in liquid and gaseous phases. There is a con-
stant evolution of design improvement for agitation and aeration; these allow better
control over flow dynamics, the minimal effect of viscosity, and even circulation of
components and nutrients. The healthy growth of culture in the batch is maintained
by supplementing nutrients such as M9 medium with FeSO4∙7H2O; M63 medium
with KOH; A medium MgSO4∙7H2O, 20% Glucose or sugar, vitamins, casamino
acids or L-amino acids [69]. Removal experiments are required for the identifica-
tion of critical components needed for the media. Certain media affect the reduc-
tion of formate, acetate, and reduction of pH. There are few examples associated
with removing glucose from complex media to prevent inhibition of bacterial
growth. Replacement experiments identifies correct nutrients complexes for nitro-
gen source yeast, soy peptone, bactotryptone, meat extract and protein powder.
The carbon sources utilised are glucose, glycerol, sucrose, lactose and others. The
use of OFAT for designing of media for fermentation limits number of experiments,
the approach is suitable for production of metabolite. In one study, precursor
carbohydrate phosphotransferase system (PTS) encoding genes a vital DXP path-
way were deleted. This resulted in the enrichment of Isoprenoid phosphoenolpyr-
uvate. Growth medium and production of lycopene (a C40 isoprenoid) resulted in
maximisation by these culture conditions [70].
Defined media recipes used in the fermentation of E. coli include nine mineral
salts in usually salts of ammonium, potassium and sodium cations; and carbonate,
chloride, nitrate and sulphate anions. Glucose, Glycerol and ammonia were identi-
fied as potential additional sources of carbon and nitrogen, respectively. EDTA is a
chelating agent, and seven trace elements are Iron chloride, Zinc chloride, Cobalt
chloride, Sodium molybdate, calcium chloride, cuprous chloride, and Boric acid.
The vitamins included in the experimental design solutions were Riboflavin,
Panthothenic acid, nicotinic acid, Piridoxin, Biotin, and folic acid. In complex
media, yeast extract ranges from 1 to 1.6 g L1, is varied during preliminary con-
centrations. Screening designs often involve many factors and allow for initial
differentiation of significant and non-significant factors and an estimation of the
magnitude of the critical factors. A Full Factorial design, including 24 factors,
would require almost 20 million experimental treatments. Fractional Factorial plat-
form of the Design expert or JMP software can be used to generate 32 experimental
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treatments, randomly distributed into eight blocks. Each block comprised eight
treatments and provided information on a technical error, a positive control, and
negative control. These results are calculated using standard algorithms in the
software.
E. coli growth was studied with nine continuous factors. The media ingredients
in the first iteration were found to be influencing optical density in relation to time.
For this study custom design platform of the Design expert software was used to
construct a design that balanced the need to maximise the information that could be
gathered from the experiment whilst minimising resources and time. Total number
of experiments and concentration of yeast extract tested in 50–60 experiments is
determined 10 g L1 to be the optimal concentration [15].
3.2 Statistical designs for E. coli Media optimization
Typically, statistical medium optimisation is beneficial in improving overall
product output, reduces time needed for process development and cost. The micro-
bial processes have complex reactions. Evaluation of results statistically increases
the reliability of results, further reduction in the number of experiments. In one of
the study, the GDP mannose pyrophosphate yield was improved upto 100% after
conducting 33 experiments [61]. Improvement of media by DOE is for understand-
ing various test variants, multiple investigations, and uniform pattern. The results
obtained after the various experiments are used to predict media improvement
using mathematical models. The current advancement in statistical techniques pro-
vides rapid analysis of experimental findings. Meticulously planned experiments
can enhance the desired outcomes using DOE strategies. For designing a full facto-
rial, possible combinations of relevant factors, e.g. temperature, pH, buffers, car-
bon, nitrogen sources, strain, are considered. Similarly, partial factorial design is
considered if knowledge about few components is not available. These experiments
if planned and output is studied properly results in quick and definitive reproduc-
ible processes.
3.3 Identification of critical components: Plakett Burman design
Cultivation at a large scale requires a medium that will produce maximum yield
of product per gram of substrate, maximum biomass and minimum undesirable by-
products. Also, consisten with minimal problems during media preparation and
sterilisation. While considering the biomass in isolation, it must be recognised that
efficiently grown biomass produced by an optimised high productivity growth rate
is not necessarily best suited for its ultimate purpose, such as synthesising the
desired product. Different combination, and sequences of process condition need to
be investigated to determine phases, specific sets of conditions during optimisation.
OFAT for media optimisation using traditional replacement experiments with
keeping one factor at a time for nutrient, antifoam, pH, temperature are highly
time-consuming and expensive. Minimum number of experiments and develop-
ment of process in short duration of time is prerequisite to media optimisation.
Therefore, other alternative strategies must be considered, which allows more than
one variable to be changed at a time, and these methods have been described in
earlier studies by Placket and Burman 1946, and Hendrix 1980 (Table 3).
The Plakett Burman algorithm is a rapid statistical approach enables us to obtain
the physicochemical parameters and factors influencing the fermentation process
with the limited number of planned experiments [71]. For the given number of
observation, the linear effect of all aspects are screened with maximum accuracy.
The design is practical when investigating a large number of factors to produce an
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optimal or near-optimal response. Statistically optimised media design along with
kinetic models characterises the fermentation behaviour more rapidly to achieve
maximum productivity. Also, when complex carbon-nitrogen substrates, such as
yeast extract or peptone, are used together with carbohydrate substrates, the
Dissolved Oxygen (DO) change is not as significant when the carbon source is
depleted, as cells continue to utilise the complex substrates [72]. The use of a good
reliable model is essential to develop better strategies for optimising the fermenta-
tion process [73]. In one the study, during production of succinic acid [71] increas-
ing output was achieved by combining Plackett-Burman design (PBD), steepest
ascent method (SA), and Box–Behnken design (BBD) for fermentation medium.
PBD identified Glucose, yeast extract, and MgCO3 as critical components with
optimal concentration was located to be 84.6 g L1 of glucose, 14.5 g L1 of yeast
extract, and 64.7 g L1 of MgCO3 [2]. Also, the productivity was enhanced by 67.3%
and 111.1%, respectively. Microbial fermentation for L-methionine (L-Met) pro-
duction was enhanced by Plackett-Burman (PB) design, and Box–Behnken design
(BBD) estimated glucose 37.43 g/L, yeast extract 0.95 g/L, KH2PO4 1.82 g/L, and
MgSO4.7H2O 4.51 g/L), L-Met titre was increased to 3.04 g/L from less than 2.0 g/L.
an increase of 38.53% and 30.0% compared with those of the basal medium,
respectively. Furthermore, higher L-Met productivity of 0.261 g/L/h was obtained,
representing 2.13-fold higher in comparison to the original medium [14].
In another study, yield of O-succinyl-l-homoserine (OSH) was improved
through multilevel fermentation optimisation; Plackett-Burman design was used to
screen out three factors (glucose, yeast and threonine) from the original 11 factors
that improved the titre of OSH.
Plackett Burman randomisation is an excellent tool for the determination of the
effect of variables for optimisation. Once such approach for preparation of Bacterial
Ghosts (BGs) preparation is established using these methods. The twelve experi-
ments containing either the +1 or  1 value for each variable in each experiment in
random arrangement have been conducted simultaneously to get the best results
and enable the best possible comparison. The BGQ has been given 100% quality as
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6
Std Run A:Select Soytone B:Yeast Extract C:Glucose D:Buffer E:Trace Metals F:MgSO4
g/L g/L g/L g/L
6 1 0 0 0 Present Absent 0.4
5 2 0 0 20 Absent Present 0.4
9 3 16 24 20 Absent Absent 0
11 4 16 0 20 Present Present 0
1 5 16 24 0 Present Present 0.4
8 6 16 24 0 Absent Absent 0.4
10 7 0 24 20 Present Absent 0
3 8 16 0 20 Present Absent 0.4
7 9 16 0 0 Absent Present 0
4 10 0 24 0 Present Present 0
2 11 0 24 20 Absent Present 0.4
12 12 0 0 0 Absent Absent 0
Table 3.
Plackett-Burman design of experiments for media optimization (complex media example).
12
Fermentation - Processes, Benefits and Risks
10, while ten cells have been evaluated as either bad or good. This will decrease the
range of the differences if we use %. Unexpectedly, E. coli, which is more sensitive
to the SDS than E. coli BL21 (DE3), gives better results with most of the experi-
ments. Nine experiments provide the number 10 out of the twelve experiments.
Two give the number eight, and the only one shows the number 0, which means
inferior preparation. The experimental Design is based mainly on the determination
of Minimum Inhibition Concentration (MIC) and the Minimum Growth Concen-
tration (MGC) of critical concentrations from chemical compounds able to convert
viable cells to BGs. The mean of +1 experiments has been calculated using the
following formula:
P
þ1ð Þ=n þ1ð Þ:While the standard of 1 experiments has been
calculated using the following formula:
P
1ð Þ=n 1ð Þ:The main effect of both +1
and  1 for each variable has been calculated from the following formula: Main
product =
P
þ1ð Þ=n þ1ð Þ 
P
1ð Þ=n 1ð Þ. Multiple linear regression analysis with
ANOVA test of Plackett–Burman design has been performed on the BGQ as
responses. A multiple linear regression analysis for the data of the BGQ has been
committed to study the relationship between different variables and their level of
significance regarding BGQ as a response. From the analysis of the Coefficient,
Standard error, T Statistic, P-value and Confidence level % for each has been
calculated. The confidence level has been calculated from the formula The confi-
dence level% = 100∗(1  P-value). The P-value from the ANOVA analysis for the
BGQ response was determined to analyse the relationship between the variables at
the 90% or higher confidence level. The model created from the analysis of
Plackett–Burman experimental design using multiple regression analysis is based on
the 1st order-model Y ¼ ß0þ
P
ßiXi. Where Y is the predicted response, ß0
model intercept, ßi variables linear coefficient. ANOVA test was generated for each
response to determine the relationship between the variables at the 90% or higher
confidence level [74]. This improvement was applied for optimisation of produc-
tion of chimeric protein PfMSP3-MSP119 resulted in critical concentrations are
calculated are listed in Table 4.
3.4 Optimisation of fermentation conditions: Box-Behnken response surface
methodology
George E. P. Box and Donald Behnken in 1960 developed the Box–Behnken
response surface method. This algorithm establishes a comparison between com-
posite central, three-level full factorial and Doehlert designs to optimise the fer-
mentation conditions. In one of the example result of optimisation, the titre of
O-succinyl-l-homoserine (OSH) reached 102.5 g l1, which is 5.6 times higher than
before (15.6 g l1) [5]. Similarly, by Box–Behnken combination and Plackett-
Burman design and were optimised further by employing the Response Surface
Methodology, O-acetylhomoserine OAH production was up to 9.42 and 7.01 g/L.
The effect of glycerol, ammonium chloride and yeast extract were screened for
fermentation conditions [3].
scFv anti-HIV-1 P17 protein was optimised by the sequential simplex method.
Plackett-Burman design (PBD) and sequential simplex were combined with the aim
of improving feed medium for enhanced cell biomass, relative protein to biomass
ratio. The scFv anti-p17 activity was enhanced by 4.43, 1.48, and 6.5 times more
than batch cultivation, respectively [29].
DNA vaccine pcDNA-CCOL2A1 production was increased using the response
surface method (RSM) in E. coli DH5alpha in fermentation, therapeutic DNA vac-
cine pcDNA-CCOL2A1 markedly increased from 223.37 mg/L to 339.32 mg/L under
optimal conditions, and a 51.9% increase was observed compared with the original
medium [21]. Statistical experimental design methodology for fermentation
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conditions (dissolved oxygen, IPTG, and temperature) improved rPDT production
by E. coli. 15 Box–Behnken design augmented with centre points revealed that IPTG
and DO at the centre point and low temperature would result in high yield. The
optimal condition for rPDT production was found to be 100 mM IPTG, DO 30%,
and temperature 20°C [23]. In another application, E. coli drug susceptibility testing
was done by on-chip bacterial culture conditions using the Box–Behnken design
response surface methodology for faster drug susceptibility, optimal growth
parameters were determined within 6–8 h, MICs determination in 2–6 h of individ-
ual drugs (antibiotics and TCMs) to improve the clinical management of bacterial
infection [75].
3.5 Functional characteristics with minimum experiments—Taguchi design
There are several challenges associated with the PBD and Box–Behnken design.
To overcome these challenges of Box–Behnken new array based on “Orthogonal
Array” was developed. Using this method, less number of experiments, instead of
full factorial, is implemented. The system and technique provide control over three
stages, likewise system strategy, tolerance design and parameters designing. The
strategy design helps in determining tolerance, affecting factors in product output.
Taguchi design is using a number of OAs to initiate the experimental setup, these
arrays are utilised to suit the number of experimental iterations. Second step is
conducting total tests with orthogonal arrays. These experiments are decided as per
number of trial experiments as per Taguchi design, followed by randomisation of
Source of Variation Degrees of Freedom Sum of Squares [Partial] Mean Squares [Partial]
Model 11 32.0001 2.9091
Main Effects 11 32.0001 2.9091
Residual 0 —
Total 11 32.0001




A:Select Soytone 1.5 0.75
B:Yeast Extract 1.93 0.965
C:Glucose 0.32 0.16
D:Buffer 1.6467 0.8233
E:Trace Metals 0.4667 0.2333
F:MgSO4 0.5733 0.2867
G:Dummy 1 0.5667 0.2833
H:Dummy 2 0.6133 0.3067
J:Dummy 3 0.3733 0.1867
K:Dummy 4 0.4467 0.2233
L:Dummy 5 0.5433 0.2717
Table 4.
Plackett Burman design of experiments for media optimization after ANOVA analysis.
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experiments for determining the output. This design analyses main effect and two-
factor interactions. Noise for uncontrolled experimental variables is considered,
focal point for two-point analysis. Taguchi methodology removes effect of noise
due to uncontrolled variables; this is better as compared to PBD [76]. The Taguchi
method provides help in functional characteristic for capturing acceptable devia-
tions. Human insulin-like growth factor I (hIGF-I) was produced in one study in
E. coli, 32y media, 32°C and 0.05 mM IPTG. The unimproved hIGF-I was
0.694 g L1 which improved to 1.26 g L1 using optimum conditions [77].
3.6 Deciphering outcome with- central composite design
This design is widely used in building a second-order (quadratic) model in
response surface methodology (RSM). It consists of factorial Design with two levels
+1 and  1; centre points, factorial Design in experiments with median values; and
star points identical runs for centre points except for one factor considering values
above median and below the median. The number of star points is double the
number of factors used. CCD is defined on the level of factors: as Face centred CCD
(CCF), Inscribed CCD (CCI) and Circumcentered CCD (CCC). E. coli BL21(DE3) is
utilised for optimum Design for extracellular production of recombinant human
epidermal growth factor (rhEGF) by CCD. This resulted in 122.40 μg mL1 rhEGF
concentration in medium 20 h after induction. In 2 L fermentation, medium
optimised yield to 1.5 fold and induction time to 3 h [78].
3.7 Predicting effects of responses—partial least squares modelling
The effect of media ingredients, interactions with the system (X) and co-relation
in response to culture ΔOD600 (Y) is defined by the Partial least squares (PLS)
model. PLS covariance of matrix design and outcome are inferred accurately by
virtue of small underlying events not measured directly. The ideal or latent variable
(LVs) to study outcome needs to be carefully evaluated to avoid overfitting training
data. The prediction of the accuracy of models for DoE iterations with multiple
values, the Root Mean Predicted Residual Error Sum of Squares, is with the lowest
value of LVs, having the slightest error. The significance of LVs is calculated by the
Voet T2 test. The score of media design and component determined by OD600, the
threshold of 0.8 is accepted. The lower score of model threshold defines to remove
from subsequent designs; these threshold values are considered to study the positive
and negative effect on the contribution of various factors associated with the
increasing growth of the culture. In one study, 2D spectrofluorometry was utilised
for fermentation processes to monitor the fermentation process online to produce
extracellular 5-aminolevulinic acid (ALA). Various chemometric methods used for
analysis of the spectral data are principal component analysis (PCA), partial least
square regression (PLS) and principal component regression (PCR). PCA results
visualised and considered for online fermentation monitoring. PCR and PLS com-
pared for correlation between the 2D fluorescence spectra, PLS had slightly better
calibration and prediction performance than PCR [79].
3.8 Minimal product trial experiments—definitive screening designs
Traditional definitive screening designs (DSD) require a low number of experi-
ments and trials to determine the positive outcome. Jones and Nachtscheim devel-
oped Jones DSD methodology. These designs are popular in biopharma due to the
relatively small number of experiments. These designs use three levels for each
factor, allows estimation of nonlinear effects. Evaluate the number of runs to
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determine X is 2 X + 1 or 2X + 3 for even and odd values. Typically, the Design of
X = 6 is used if X < 6. There are few dummies runs with additional factorial or
centre points are added to precisely determine the experimental error. In DSD, few
different factorial trials or centre point trials are added to the initial design to define
and evaluate the experimental error. One such example of DSD is for upstream
process development for cell growth and increased product output in fed-batch
high-cell-density fermentation. The expression of the desired gene cloned in the
plasmid was under the control of the phoA promoter [13]. Simultaneous evaluation
of phosphate concentration from 2.79 mM to 86.4 mM was designed using DoE.
Several parameters, phosphate content, temperature, pH, and DO evaluated using a
Definite screening design (DSD), resulting in determining each parameter’s impact
on product formation. Similarly, a 24-bioreactor ambr250™ system for fermenta-
tion utilised 10-factor DSD to characterise the process of demonstrating 16 batches
reproducible workflow for recombinant protein production. This strategy was fur-
ther evaluated by QbD approaches to assess techniques for late-stage depiction in
small experiments and subsequently leading to large scale fermentation parameters
improvement [80].
3.9 Stepwise regression and artificial neural network modelling
Artificial Neural Networks (ANN) are known for parallel, and continuous
learning capabilities are known to interpret nonlinear functions. These are utilised
to predict steady-state and dynamic processes. One iteration multi-layer perceptron
(MLP) is famous for estimating hidden layers between output and input layers.
Using this method, simulation of dissolve Oxygen (DO) parameters, Feeding (F),
Biomass, Glucose, Acetate, and output production of γ-interferon is modelled.
Several DoE iteration modelled using stepwise regression; these models are fitted
with linear regression, six terms per model are allowed with Heredity Restriction.
The goodness-of-fit of the resulting model is evaluated using Akaike Information
Criterion (AICc). An artificial neural network (ANN) is used to create weighted
ensemble of regression models. There are three nodes in single hidden layer of
ANN. Sigmoid activation functions were used, cross-validation of 19 of the media
formulations defined in the second DOE iteration were randomly selected and
withheld from ANN training set to do validation studies [59].
4. DOE optimisation techniques for E. coli
4.1 Evaluation of production and process—response surface methodology
(RSM)
RSM is simple, robust and efficient, in predicting processes of metabolite or
product production. Also, this method helps in the determination of factors for
specifications, changes in levels of the elements, response with specified levels,
quantitative understanding of system behaviour, predict product properties, factor
combinations not run and stability of the designed process.
RSM methodology consists of different phases. Typically, performed in three
steps, First is the screening factors by steepest ascent/descent, secondly by qua-
dratic regression model fitting, third optimization using canonical regression
analysis.
For a cost-effective and robust process, improvising parameters related to
medium, productivity, safety and usefulness are desired outputs. The
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interdependency of factors associated with productivity is difficult to understand,
and this slows downs the enhancement process and yield evaluation.
Response surface methodology (RSM), is based on factorial designs to elevate
the process and final product yield. RSM is considered a sturdy, robust, and effi-
cient mathematical approach. It includes experimental statistical methods, multiple
regression design, and analysis, resulting in developing the best strategies guided by
constrained equations. RSM is typically applied to study the response of different
media ingredients [21]. The production of Examples for E. coli fermentation.
One such example is standardisation of production of human interferon-gamma
(hIFN-γ).







βijxixj þ ε: (3)
Where β0 is defined as the constant, Bi the linear coefficient, Bii the quadratic
coefficient and Bij the cross-product coefficient. Xi and Xj are levels of the indepen-
dent variables, while ε is the residual error. This variable and RSM predicted
7.81 g L1 glucose, 30°C for fermentation and induced at OD600 1.66, Combined
with BBD to get the 95.50% acetate and 97.96% productivity of rhIFN-β [81].
Plackett Burman design and Response surface methodology are utilised together
to increase the production of the desired product multiple-fold. Combining these
techniques is usually employed to enhance the product outcome of several micro-
bial processes, batch, fed-batch fermentation. RSM is widely used, with Plackett
Burman, CCD, Box Benken. Even after much success, several limitations are asso-
ciated with RSM, likewise predicting responses based on second-order polynomial
equation [82], results in poor estimation of optimal designs, leading to low levels of
yield or outcome. One limitation is developing a model for many variables on
physical and chemical inputs due to nonlinear biochemical network interactions,
with partial knowledge of these systems [83]. Another limitation is the study of
multiple interactions and significant variations, resulting in error, bias and or no
reproducibility. These challenges are dealt with better using Artificial neural net-
works (ANN) [84].
4.2 Study of interaction of pathways and multiple parameters—artificial neural
network
An artificial neural network (ANN) is designed for a computing system to
simulate the information and process the data similar to the human brain, guided by
artificial intelligence (AI). It solves problems impossible or difficult by human or
statistical standards. Handling units consist of inputs and outputs; using these
inputs, ANNs produce desired or defined work. ANNs are built as neurons, are
interconnected like a web in the human brain. There are hundreds or thousands of
artificial neurons or processing units interconnected by nodes [85].
Similarly, as human functions, ANNs have a set of rules for learning
backpropagation, an abbreviation for backward propagation of error, to perfect
their output results. Typical processes in ANN are the training phase to recognise
patterns in data, whether visually, aurally, or textually; in this supervised learning,
the actual output is compared with the desired outcome. The differences are
adjusted using backpropagation. The program runs backwards as we advance, and
adjustments are made until the actual and expected output difference results in a
minimum possible error. Designing of medium or metabolic process ANN is highly
suitable, and it generates large amounts of data. The architecture of ANN consists of
three layers: a layer of “input” connected to “hidden” units, ultimately connected
with “output”. The conditions for ANNs three types are Supervised, Unsupervised
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and Reinforced learning. The objective of supervised learning for the neural net-
work is to provide input training data and possible experimental output. An
unsupervised output unit is trained to respond to clusters or patterns present in the
input data. Reinforced learning is an intermediate system; learning systems’ actions
are considered good or bad based on environmental responsibility. These parame-
ters are adjusted till the time equilibrium state is attained. These systems are applied
for system designing, modelling, optimisation. It leads to control the noisy signals
and generalise through system training procedure. The ANNs are employed in
various fermentation processes to optimise nutrient and prediction biomass out-
come in different culture conditions. ANN has several limitations; likewise, it needs
proper training, also based on input data to get the quality output [86]. To over-
come some of these challenges, ANN combined with a genetic algorithm (GA) is
applied to improve the concentration and shelf life of aspartate-β-semialdehyde
dehydrogenase protein [87].
4.3 Study of biological process of evolution- genetic algorithm (GA)
Genetic algorithm (GA), developed in 1975 by Holland and Long, is based on
Charles Darwin’s theory of natural selection. GA is a model for the study of biolog-
ical evolution by testing crossover and recombination mutation in adaptive and
artificial systems. A genetic algorithm works as a problem-solving strategy using
essential genetic operators. There are several GA designed to deal with complex
problems and parallelism for stationary or non-stationary functions, linear or
nonlinear, continuous or discontinuous, random or noise. Improvement in yield of
recombinant G-CSF was obtained in auto-induction medium. The backpropagation
(BP) algorithm and radial basis function (RBF) algorithm combined with the
Genetic Algorithm improve G-CSF yield. The yield of models was 72.24 and
76.09%, respectively, and are higher than those obtained using non-optimised auto-
induction mediums.
There are some disadvantages or genetic algorithms as well. The formulation of
the fitness function, population size, choice of factors for mutation and cross over,
selection of criteria for these factors needed to be carried out carefully. Despite
drawbacks, GA is one of the widely used algorithms in modern nonlinear
optimisation [88].
4.4 Geometric function evaluation- Nelder-Mead simplex algorithm
Nelder–Mead published this algorithm in 1965. The objective is to solve the
classical unconstrained optimisation problem of minimising a given nonlinear
function; without derivative only numerical evaluation of the objective function is
needed. This algorithm is based on geometry, and in three-dimensional space,
simplex is a tetrahedron determined by four points (vertices) and their
interconnecting line segments. For two dimensions, simplex is an equilateral
triangle, and three dimensions should be tetrahedron. The objective function is
evaluated every point with the highest numerical value of all four points is perpen-
dicularly mirrored against the opposite plain segment, generating reflection [89].
An expansion can accompany the reflection to take more significant steps or a
contraction to shrink the simplex where an optimisation valley floor is reached. The
optimisation procedure continues until the termination criteria are met. The termi-
nation criterion is usually the maximum number of reflections with contractions or
tolerance for optimisation variables. The algorithm can be implemented in N
dimensions, where simplex is a hypercube with N + 1 vertex points. The NM
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method provides significant improvements in primary iteration and improves out-
come. NM is combined with ANN to optimise the production of metabolites [90].
5. Problems and bottlenecks in E. coli media optimisation
Medium optimisation involves many experiments irrespective of the media
chosen, which accounts for labour cost and is an open-ended experiment. Many
experiments are carried out at shake flask, even after generation of large amount of
data using single experiments. The results obtained at piolet scale batch fermenta-
tion are not reproducible. During shake flask experiments, the precise control over
pH, oxygen transfer and evaporation is not controlled. The experiments carried out
at shake flask may or may replicate during fermentation. Also, soluble proteins
expression may lead to inclusion bodies formation. Optimisation of media is time
consuming due to the requirement of rigorous experimental planning. Moreover,
the media utilised in the production of recombinant products faces challenges due
to variability in different batches, media availability, cost of media, bulk storage,
transport time. For Biotherapeutics, Enzymes and Probiotics, the cost of media
needs to lower in Probiotics compared to Enzymes and Biotherapeutics, respec-
tively. The choice of fermentation depends on the solubility of protein from batch
to fed-batch. E. coli cells are dynamic, and every product requires different media
compared to the earlier optimised process. Optimisation of media depends on
considering dynamic internal control mechanisms. For the production of metabolites
after engineering of bacterial strains, metabolic pathways needed to be optimised to
regulate the desired product by choice of media. The influence of using different
strains for the production is dependent on toxicity, complexity (Disulphide bonds in
the sequence), AT-rich sequences. In our previous study, E. coli cell Shuffle 3030H
for production of Plasmodium falciparumMSP-3 and the MSP-119 fusion protein was
successfully optimised to generate protective antibodies [91].
Improvement of production of recombinant products is also guided by down-
stream processing of protein. Therefore, series of experiments designed for correct
folding and confirmation are most important. Significant protein amounts can be
achieved using pH, time for fermentation, oxygen transfer and temperature for
fermentation. Also, inducer and harvest time are critical for increasing output. The
critical factors for fermentation in batch and fed-batch are different. Therefore, the
choice of media defined, semi-defined or complex media with vitamins, minerals
and trace elements needed to be considered for evaluation in DOE experiments. To
evaluate the considerable amount of output and variables combination and applica-
tion of various algorithms is done to achieve desired output. In all the optimisation
process and advanced algorithms such as Artificial neural networks and Genetic
Algorithm are applied to achieve the desired output efficiently. The need for inno-
vation as per sustainable development goals (SDGs) for United Nations 2030 plan is
needed to increase the reach of technologies to low income countries. The
application of DOE can improve the yield and cost leading to improved access to
Biomolecules, Biopharmaceuticals, enzymes and metabolites.
6. Future strategies
The selection of host cells for industrial application has some technical difficul-
ties despite the availability of many gene manipulations theoretically in various
organisms. The availability of a genetic map, gene exchange system, useful vector
and transformation procedures, and metabolic pathways leading from raw material
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to the desired product are essential criteria for selecting a suitable host strain. The
most popular organisms used to date for the expression of the recombinant proteins
are E. coli, Bacillus subtilis, Bacillus stearothermophillus, Streptomyces spp, Corynebac-
terium, Saccharomyces cerevisiae, Pichia pastoris, Hansenula polymorpha and various
animal/plant cells. E. coli remains an important host system for the industrial pro-
tein production from cloned genes as one of the main applications of genetic engi-
neering in biotechnology. Various efficient expression vector systems have been
developed, and a variety of mutants are available as host strains for different
purposes [92, 93]. Overexpression of a heterologous protein is possible in E. coli,
making it suitable for industrial production. Fermentation DOE is an essential tool
for basic research that greatly facilitates efficient purification and analysis of such
proteins [94].
For the successful production of the recombinant protein-based vaccine, pro-
ducing biologically active protein is an essential requirement that can be further
scaled up. Production of a biologically active recombinant protein depends on the
host cell’s microenvironment for expression and compatibility of codon usage. E.
coli has been a widely used expression host for the high-level production of heter-
ologous protein. Differences in usage of codons in prokaryotes (E. coli) and eukary-
otes Chinese hamster ovary cells (CHO) can substantially impact heterologous
protein production. The compatibility of codon usage can significantly increase
protein expression [95, 96]. Moreover, the presence of rare codons in cloned genes
affects protein expression level and mRNA & plasmid stability. The excessive
presence of rare codons may result in ribosome stalling, slow translation errors
[96, 97]. In some cases, rare codons inhibit protein synthesis and cell growth [98].
Earlier studies of codon usage patterns in E. coli have established that a clear codon
bias exists in the mRNA. The level of each cognate tRNA seems to be directly
proportional to the codon frequency [99, 100]. The strategy widely used is to
change rare codons in the target gene to the favoured codons of E. coli without
affecting the encoded amino acid sequence [101, 102]. The second approach is to
expand the intracellular tRNA pool by introducing a plasmid encoding additional
copies of tRNAs for codons rarely used in E. coli [103]. The co-presence of the RIG
plasmid encoding three tRNAsAG(A/G), ATA, GGA in the host cells significantly
increases the expression level of Dihydropteroate synthase, Aldolase, Phosphatase,
and Orotidine-50-monophosphate decarboxylase of P. falciparum [104–106]. Codon
optimisation for maximum expression of foreign proteins by changing host cell
favourable codons is beneficial and crucial for large-scale proteins [107].
The recombinant plasmid carrying cloned gene would behave differently com-
pared to the original vector plasmid. It can be easily understood, as it is preserved
under a delicate quasi-equilibrium state in the host cell. There are several reasons for
the instability of recombinants. The higher the plasmid gene expression, the more
segregants (plasmid free cells) tend to appear. The recombinant plasmid is relatively
unstable when the cloned gene products are inhibitory to the host cells. Phenotypic
instability of plasmid is due to the disappearance of the entire plasmid or the deletion
of a specific region [108]. Both plasmid copy number and plasmid loss rate are
features affected by factors such as media composition growth rate and culture
strategy [109] and other factors such as temperature, agitation rate, and pH [110].
Therefore, future strategies for optimisation of cultivations needed to be shift to
conclusions evaluated during experimental phases before actual fermentation to
identify role of batch, fed-batch or different media components. The utilisation of
carbon, nitrogen and other minimally required nutrients during batch and fed-
batch is critical for delivering output and achieve sustainable development goals
(SDGs) for technological innovation. The method design and modelling approaches
are future strategies for increasing output during a process development. Utilisation
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of one factor and carrying out experiments by statistical media optimisation can be
improved by combining several algorithms such as Plakett Burman, Box–Behnken,
Taguchi design, Central composite design, partial least squares modelling in
determining optimal factors. Response surface methodology with Artificial neural
network (ANNs) can be applied to difficult model kind of fermentation processes.
A free artificial neural network is applicable for carrying out nonlinear regression
models to optimise metabolic processes. These algorithms are combined and applied
to increase productivity and optimise the product output by reducing the cost of
fermentation and product development.
7. Conclusions
Optimisation of critical factors and nutrient sources is an essential step for
metabolite, recombinant proteins before pilot fermentation. In this chapter, strate-
gies, conventional, advanced process design are reviewed and detailed. DOE
approaches with statistical evaluation are critical for process development are
essential for saving experimentation time. The strategies and examples shared in
this review have been analysed for ease of implementation, time consumption. The
conditions and media designed needs to be further tested under realistic conditions,
full scale process with replication to production setup.
Overall, this chapter detailed need of critical factors identification, their signifi-
cant contribution in enhancing process of metabolite production. Also, recently, co-
fermentation of glycerol and glucose in engineered E. coli increased production of 1,
3 propanediol [1]. Similarly, O-acetylhomoserine production is increased by suit-
able designs for fermentation and modification of glycerol-Oxidative pathway [3].
Production of recombinant protein in one study response surface methodology was
utilised for production of repletase and improved yield to 188 mg L1 of fermenta-
tion [15]. The approaches discussed in this chapter have several advantages for
improving the yield and reduction of resource utilisation. These approaches are
efficient for achieving the access for biotechnologically produced products to reach
the larger population across the globe.
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DSD Definitive screening designs
QbD Quality by design
ANN Artificial Neural Network
GA Genetic Algorithm
NM Nelder–Mead
SDGs Sustainable Development Goals
CHO Chinese Hamster Ovary
Author details
Puneet Kumar Gupta1* and Jyotheeswara Reddy Edula2
1 Grace Lifetech Pvt. Ltd., New Delhi, India
2 Tata Institute of Genetics and Society, Bangalore, Karnataka, India
*Address all correspondence to: guptapuneetin@gmail.com
©2021 TheAuthor(s). Licensee IntechOpen. This chapter is distributed under the terms
of theCreativeCommonsAttribution License (http://creativecommons.org/licenses/
by/3.0),which permits unrestricted use, distribution, and reproduction in anymedium,
provided the original work is properly cited.
22
Fermentation - Processes, Benefits and Risks
References
[1] Yun J, Zabed HM, Zhang Y,
Parvez A, Zhang G, Qi X. Co-
fermentation of glycerol and glucose by
a co-culture system of engineered
Escherichia coli strains for 1,3-
propanediol production without vitamin
B12 supplementation. Bioresour
Technol. 2020/10/14 ed2021. p. 124218.
[2] Xu JM, Cao HT, Wang M, Ma BJ,
Wang LY, Zhang K, et al. 2021.
Development of a Combination
Fermentation Strategy to
Simultaneously Increase Biomass and
Enzyme Activity of D-amino Acid
Oxidase Expressed in Escherichia coli.
Appl Biochem Biotechnol. DOI:
10.1007/s12010-021-03519-7.
[3] Liu P, Liu JS, Zhang B, Liu ZQ,
Zheng YG. 2021. Increasement of O-
acetylhomoserine production in
Escherichia coli by modification of
glycerol-oxidative pathway coupled
with optimisation of fermentation.
Biotechnol Lett 43 (1):105-117. DOI:
10.1007/s10529-020-03031-8.
[4]Datta P, Fu L, Brodfuerer P,
Dordick JS, Linhardt RJ. 2021. High
density fermentation of probiotic E. coli
Nissle 1917 towards heparosan
production, characterisation, and
modification. Appl Microbiol Biotechnol
105 (3):1051-1062. DOI: 10.1007/
s00253-020-11079-9.
[5] Zhu WY, Niu K, Liu P, Fan YH,





multilevel fermentation optimization. J
Appl Microbiol. DOI: 10.1111/
jam.14884.
[6] Zhou S, Hao T, Zhou J. 2020.
Fermentation and Metabolic Pathway
Optimization to De Novo Synthesize
(2S)-Naringenin in Escherichia coli. J
Microbiol Biotechnol 30 (10):1574-1582.
DOI: 10.4014/jmb.2008.08005.
[7] Zhao C, Fang H, Wang J, Zhang S,
Zhao X, Li Z, et al. 2020. Application of
fermentation process control to increase
l-tryptophan production in Escherichia
coli. Biotechnol Prog 36 (2):e2944. DOI:
10.1002/btpr.2944.
[8] Yao P, You S, Qi W, Su R, He Z.
2020. Investigation of fermentation
conditions of biodiesel by-products for
high production of beta-farnesene by an
engineered Escherichia coli. Environ Sci
Pollut Res Int 27 (18):22758-22769. DOI:
10.1007/s11356-020-08893-z.
[9] Xu D, Zhang Z, Liu Z, Xu Q. 2020.
Using enzymatic hydrolyzate as new
nitrogen source for L-tryptophan
fermentation by E.coli. Bioengineered 11
(1):1-10. DOI: 10.1080/
21655979.2019.1700092.
[10]Wang J, Liu Y, Chen Y, Wang A,
Wei Q, Liu D, et al. 2020. Large-scale
manufacture of VP2 VLP vaccine
against porcine parvovirus in
Escherichia coli with high-density
fermentation. Appl Microbiol
Biotechnol 104 (9):3847-3857. DOI:
10.1007/s00253-020-10483-5.
[11] Li D, Fang H, Gai Y, Zhao J, Jiang P,
Wang L, et al. 2020. Metabolic
engineering and optimisation of the
fermentation medium for vitamin B12
production in Escherichia coli. Bioprocess
Biosyst Eng 43 (10):1735-1745. DOI:
10.1007/s00449-020-02355-z.
[12]Hao Y, Ma Q, Liu X, Fan X, Men J,
Wu H, et al. 2020. High-yield
production of L-valine in engineered
Escherichia coli by a novel two-stage
fermentation. Metab Eng 62:198-206.
DOI: 10.1016/j.ymben.2020.09.007.
[13] Agbogbo FK, Ramsey P, George R,
Joy J, Srivastava S, Huang M, et al. 2020.
23
Strategies for Enhancing Product Yield: Design of Experiments (DOE) for Escherichia coli…
DOI: http://dx.doi.org/10.5772/intechopen.99288
Upstream development of Escherichia
coli fermentation process with PhoA
promotdesignng design of experiments
(DoE). J Ind Microbiol Biotechnol 47
(9–10):789-799. DOI: 10.1007/
s10295-020-02302-7.
[14] Zhou HY, Wu WJ, Niu K, Xu YY,
Liu ZQ, Zheng YG. 2019. Enhanced L-
methionine production by genetically
engineered Escherichia coli through
fermentation optimisation. 3 Biotech 9
(3):96. DOI: 10.1007/s13205-019-1609-8.
[15] Zare H,MirMohammad Sadeghi H,
Akbari V. 2019. Optimisation of
Fermentation Conditions for Reteplase
Expression by Escherichia coli Using
Response SurfaceMethodology. Avicenna
JMed Biotechnol 11 (2):162-168.
[16] Xu Y, Yang L, Zhao S, Wang Z.
2019. Large-scale production of
tauroursodeoxycholic acid products
through fermentation optimisation of
engineered Escherichia coli cell factory.
Microb Cell Fact 18 (1):34. DOI:
10.1186/s12934-019-1076-2.
[17] Tang XL, Wang ZC, Yang J,
Zheng RC, Zheng YG. 2019. Statistical
medium optimisation and DO-STAT
fed-batch fermentation for enhanced
production of tyrosine phenol lyase in
recombinant Escherichia coli. Prep
Biochem Biotechnol 49 (2):117-126.
DOI: 10.1080/10826068.2018.1541808.
[18]Horner M, Gerhardt K, Salavei P,
Hoess P, Harrer D, Kaiser J, et al. 2019.
Production of Phytochromes by High-
Cell-Density E. coli Fermentation. ACS
Synth Biol 8 (10):2442-2450. DOI:
10.1021/acssynbio.9b00267.
[19] Fang Z, Sha C, Peng Z, Zhang J,
Du G. 2019. Protein engineering to
enhance keratinolytic protease activity
and excretion in Escherichia coli and its
scale-up fermentation for high
extracellular yield. Enzyme Microb
Technol 121:37-44. DOI: 10.1016/j.
enzmictec.2018.11.003.
[20] Chen T, Liu N, Ren P, Xi X, Yang L,
Sun W, et al. 2019. Efficient Biofilm-
Based Fermentation Strategies for L-
Threonine Production by Escherichia
coli. Front Microbiol 10:1773. DOI:
10.3389/fmicb.2019.01773.
[21] Long J, Zhao X, Liang F, Liu N,
Sun Y, Xi Y. 2018. Optimisation of
fermentation conditions for an
Escherichia coli strain engineered using
the response surface method to produce
a novel therapeutic DNA vaccine for
rheumatoid arthritis. J Biol Eng 12:22.
DOI: 10.1186/s13036-018-0110-y.
[22] Liang J, Zhao J, Wang Z, Wang Y.
2018. Temperature gradient-based high-
cell density fed-batch fermentation for
the production of pyruvate oxidase by
recombinant E. coli. Prep Biochem
Biotechnol 48 (2):188-193. DOI:
10.1080/10826068.2018.1425709.
[23] Koopaei NN, Khadiv-Parsi P,
KhoshayandMR,MazlomiMA,
Kebriaeezadeh A,MoloudianH, et al.
2018. Optimisation of rPDT fusion protein
expression byEscherichia coli in pilot scale
fermentation: a statistical experimental
design approach. AMBExpress 8 (1):135.
DOI: 10.1186/s13568-018-0667-3.
[24] Jing J, Chen Y, Sheng L, Wu M.
2018. Optimised production of insulin
variant, a recombinant platelet
aggregation inhibitor, by high cell-
density fermentation of recombinant
Escherichia coli. Protein Expr Purif 152:
7-12. DOI: 10.1016/j.pep.2018.07.001.
[25] Sar T, Seker G, Erman AG,
Stark BC, Yesilcimen Akbas M. 2017.
Repeated batch fermentation of
immobilised E. coli expressing
Vitreoscilla hemoglobin for long-term
use. Bioengineered 8 (5):651-660. DOI:
10.1080/21655979.2017.1303024.
[26] Fu X, Wang Y, Wang J, Garza E,
Manow R, Zhou S. 2017. Semi-industrial
scale (30 m(3)) fed-batch fermentation
for the production of D-lactate by
24
Fermentation - Processes, Benefits and Risks
Escherichia coli strain HBUT-D15. J Ind
Microbiol Biotechnol 44 (2):221-228.
DOI: 10.1007/s10295-016-1877-9.
[27] Couto MR, Rodrigues JL,
Rodrigues LR. 2017. Optimisation of
fermentation conditions for the
production of curcumin by engineered
Escherichia coli. J R Soc Interface 14
(133). DOI: 10.1098/rsif.2017.0470.
[28] Zheng H, Yu Z, Fu X, Li S, Xu J,
Song H, et al. 2016. High level
extracellular production of a truncated
alkaline beta-mannanase from
alkaliphilic Bacillus sp. N16-5 in
Escherichia coli by the optimisation of
induction condition and fed-batch
fermentation. J Ind Microbiol
Biotechnol 43 (7):977-987. DOI:
10.1007/s10295-016-1773-3.
[29] Paopang P, Kasinrerk W,
Tayapiwatana C, Seesuriyachan P,
Butr-Indr B. 2016. Multiparameter
optimisation method and enhanced
production of secreted recombinant
single-chain variable fragment against
the HIV-1 P17 protein from Escherichia
coli by fed-batch fermentation. Prep
Biochem Biotechnol 46 (3):305-312.
DOI: 10.1080/10826068.2015.1031388.
[30] Lu XX, Yi Y, Su QD, Bi SL. 2016.
Expression and Purification of
Recombinant Hepatitis Delta Virus
(HDV) Antigen for Use in a Diagnostic
ELISA for HDV Infection Using the
High-Density Fermentation Strategy in
Escherichia coli. Biomed Environ Sci 29
(6):417-423. DOI: 10.3967/bes2016.054.
[31]Huang L, Wang Q, Jiang S, Zhou Y,
Zhang G, Ma Y. 2016. Improved
extracellular expression and high-cell-
density fed-batch fermentation of
chitosanase from Aspergillus Fumigatus
in Escherichia coli. Bioprocess Biosyst
Eng 39 (11):1679-1687. DOI: 10.1007/
s00449-016-1643-4.
[32] Sohoni SV, Nelapati D, Sathe S,
Javadekar-Subhedar V, Gaikaiwari RP,
Wangikar PP. 2015. Optimisation of
high cell density fermentation process
for recombinant nitrilase production
in E. coli. Bioresour Technol 188:
202-208. DOI: 10.1016/j.biortech.
2015.02.038.
[33]Morowvat MH, Babaeipour V, Rajabi
Memari H, Vahidi H. 2015. Optimisation
of Fermentation Conditions for
Recombinant Human Interferon Beta
Production by Escherichia coli Using the
Response Surface Methodology.
Jundishapur J Microbiol 8 (4):e16236.
DOI: 10.5812/jjm.8(4)2015.16236.
[34]Minamoto T, Takahashi N,
Kitahara S, Shinozaki Y, Hirano T,
Hakamata W, et al. 2015.
Saccharification of beta-chitin from
squid pen by a fermentation method
using recombinant chitinase-secreting
Escherichia coli. Appl Biochem
Biotechnol 175 (8):3788-3799. DOI:
10.1007/s12010-015-1547-9.
[35]Munoz-Gutierrez I, Moss-Acosta C,
Trujillo-Martinez B, Gosset G,
Martinez A. 2014. Ag43-mediated
display of a thermostable beta-
glucosidase in Escherichia coli and its
use for simultaneous saccharification
and fermentation at high temperatures.
Microb Cell Fact 13:106. DOI: 10.1186/
s12934-014-0106-3.
[36] Li Q, Mannall GJ, Ali S, Hoare M.
2013. An ultra scale-down approach to
study the interaction of fermentation,
homogenisation, and centrifugation for
antibody fragment recovery from rec E.
coli. Biotechnol Bioeng 110 (8):
2150-2160. DOI: 10.1002/bit.24891.
[37] Xu J, Qian Y, Skonezny PM, You L,
Xing Z, Meyers DS, et al. 2012.
Reduction of N-terminal methionylation
while increasing titer by lowering
metabolic and protein production rates
in E. coli auto-induced fed-batch
fermentation. J Ind Microbiol
Biotechnol 39 (8):1199-1208. DOI:
10.1007/s10295-012-1127-8.
25
Strategies for Enhancing Product Yield: Design of Experiments (DOE) for Escherichia coli…
DOI: http://dx.doi.org/10.5772/intechopen.99288
[38] Silva R, Ferreira S, Bonifacio MJ,
Dias JM, Queiroz JA, Passarinha LA.
2012. Optimisation of fermentation
conditions for the production of human
soluble catechol-O-methyltransferase by
Escherichia coli using artificial neural
network. J Biotechnol 160 (3–4):
161-168. DOI: 10.1016/j.
jbiotec.2012.03.025.
[39] Seo MJ, Choi HJ, Chung KH,
Pyun YR. 2011. Production of a platelet
aggregation inhibitor, salmosin, by high
cell density fermentation of
recombinant Escherichia coli. J
Microbiol Biotechnol 21 (10):1053-1056.
DOI: 10.4014/jmb.1105.05014.
[40] Premsukh A, Lavoie JM, Cizeau J,
Entwistle J, MacDonald GC. 2011.
Development of a GMP Phase III
purification process for VB4-845, an
immunotoxin expressed in E. coli using
high cell density fermentation. Protein
Expr Purif 78 (1):27-37. DOI: 10.1016/j.
pep.2011.03.009.
[41]Honghong J, Fuping L, Yu L,
Xiaoguang L, Yihan L, HongbinW, et al.
2011. Synthesis of GDP-mannose using
coupling fermentation of recombinant
Escherichia coli. Biotechnol Lett 33 (6):
1145-1150. DOI: 10.1007/s10529-011-
0547-2.
[42]Wang Z, Ly M, Zhang F, Zhong W,
Suen A, Hickey AM, et al. 2010. E. coli
K5 fermentation and the preparation of
heparosan, a bioengineered heparin
precursor. Biotechnol Bioeng 107 (6):
964-973. DOI: 10.1002/bit.22898.
[43] Brusehaber E, Schwiebs A,
Schmidt M, Bottcher D,
Bornscheuer UT. 2010. Production of
pig liver esterase in batch fermentation
of E. coli Origami. Appl Microbiol
Biotechnol 86 (5):1337-1344. DOI:
10.1007/s00253-009-2392-y.
[44] Zhang D, Wang PG, Qi Q. 2007. A
two-step fermentation process for
efficient production of penta-N-acetyl-
chitopentaose in recombinant
Escherichia coli. Biotechnol Lett 29 (11):
1729-1733. DOI: 10.1007/s10529-007-
9462-y.
[45] Kim M, Elvin C, Brownlee A,
Lyons R. 2007. High yield expression of
recombinant pro-resilin: lactose-
induced fermentation in E. coli and
facile purification. Protein Expr Purif 52
(1):230-236. DOI: 10.1016/j.
pep.2006.11.003.
[46] Yazdani SS, Shakri AR, Chitnis CE.
2004. A high cell density fermentation
strategy to produce recombinant
malarial antigen in E. coli. Biotechnol
Lett 26 (24):1891-1895. DOI: 10.1007/
s10529-004-6040-4.
[47] Kleist S, Miksch G, Hitzmann B,
Arndt M, Friehs K, Flaschel E. 2003.
Optimisation of the extracellular
production of a bacterial phytase with
Escherichia coli by using different fed-
batch fermentation strategies. Appl
Microbiol Biotechnol 61 (5–6):456-462.
DOI: 10.1007/s00253-003-1229-3.
[48] Khalilzadeh R, Shojaosadati SA,
Bahrami A, Maghsoudi N. 2003. Over-
expression of recombinant human
interferon-gamma in high cell density
fermentation of Escherichia coli.
Biotechnol Lett 25 (23):1989-1992. DOI:
10.1023/b:bile.0000004390.98648.25.
[49] Panda AK, Ghorpade A,
Mukhopadhyay A, Talwar GP, Garg LC.
1995. High cell density fermentation of
recombinant Vibrio cholerae for the
production of B subunit of Escherichia
coli enterotoxin. Biotechnol Bioeng 45
(3):245-250. DOI: 10.1002/
bit.260450309.
[50] Sakamoto S, Terada I, Iijima M,
Matsuzawa H, Ohta T. 1994.
Fermentation conditions for efficient
production of thermophilic protease in
Escherichia coli harboring a plasmid.
Appl Microbiol Biotechnol 42 (4):
569-574. DOI: 10.1007/BF00173922.
26
Fermentation - Processes, Benefits and Risks
[51] Kapralek F, Jecmen P, Sedlacek J,
Fabry M, Zadrazil S. 1991. Fermentation
conditions for high-level expression of
the tac-promoter-controlled calf
prochymosin cDNA in Escherichia coli
HB101. Biotechnol Bioeng 37 (1):71-79.
DOI: 10.1002/bit.260370111.
[52]Herber WK, Bailey FJ, Carty CE,
Heimbach JC, Maigetter RZ. 1991.
Production of cytotoxic proteins in
Escherichia coli: a fermentation process
for producing enzymatically active HIV-
1 protease. Appl Microbiol Biotechnol 36
(2):149-152. DOI: 10.1007/BF00164410.
[53] Chang LL, Hwang LY, Hwang CF,
Mou DG. 1991. Study of high density
Escherichia coli fermentation for
production of porcine somatotropin
protein. Ann N Y Acad Sci 646:
259-272. DOI: 10.1111/j.1749-6632.1991.
tb18589.x.
[54] Riesenberg D, Menzel K, Schulz V,
Schumann K, Veith G, Zuber G, et al.
1990. High cell density fermentation of
recombinant Escherichia coli expressing
human interferon alpha 1. Appl
Microbiol Biotechnol 34 (1):77-82. DOI:
10.1007/BF00170927.
[55] Jung G, Denefle P, Becquart J,
Mayaux JF. 1988. High-cell density
fermentation studies of recombinant
Escherichia coli strains expressing
human interleukin-1 beta. Ann Inst
Pasteur Microbiol 139 (1):129-146. DOI:
10.1016/0769-2609(88)90100-7.
[56] Botterman JH, De Buyser DR,
Spriet JA, Zabeau M, Vansteenkiste GC.
1985. Fermentation and recovery of the
EcoRI restriction enzyme with a
genetically modified Escherichia coli
strain. Biotechnol Bioeng 27 (9):
1320-1327. DOI: 10.1002/bit.260270908.
[57] Zhang J, Greasham R. 1999.
Chemically defined media for
commercial fermentations. Applied
microbiology and biotechnology 51 (4):
407-421. DOI: 10.1007/s002530051411.
[58]Nikel PI, Pettinari MJ, Galvagno MA,
Méndez BS. 2008. Poly(3-
hydroxybutyrate) synthesis from glycerol
by a recombinant Escherichia coli arcA
mutant in fed-batch microaerobic
cultures. Applied microbiology and
biotechnology 77 (6):1337-1343. DOI:
10.1007/s00253-007-1255-7.
[59] Singleton C, Gilman J, Rollit J,
Zhang K, Parker DA, Love J. 2019. A
design of experiments approach for the
rapid formulation of a chemically
defined medium for metabolic profiling
of industrially important microbes.
PLoS One 14 (6):e0218208. DOI:
10.1371/journal.pone.0218208.
[60] Singh V, Haque S, Niwas R,
Srivastava A, Pasupuleti M, Tripathi CK.
2016. Strategies for Fermentation
Medium Optimisation: An In-Depth
Review. Front Microbiol 7:2087. DOI:
10.3389/fmicb.2016.02087.
[61]Weuster-Botz D. 2000.
Expedesignal design for fermentation
media development: Stadesignal design
or global random search? Journal of
Bioscience and Bioengineering 90 (5):
473–83. DOI: https://doi.org/10.1016/
S1389-1723(01)80027-X.
[62]Weissman SA, Anderson NG. 2015.
Design of Experiments (DoE) and
Process Optimisation. A Review of
Recent Publications. Organic Process
Research & Development 19 (11):
1605-1633. DOI: 10.1021/op500169m.
[63]Dvorak P, Chrast L, Nikel PI,
Fedr R, Soucek K, Sedlackova M, et al.
2015. Exacerbation of substrate toxicity
by IPTG in Escherichia coli BL21(DE3)
carrying a synthetic metabolic pathway.
Microbial Cell Factories 14 (1):201. DOI:
10.1186/s12934-015-0393-3.
[64] Cardoso VM, Campani G,
Santos MP, Silva GG, Pires MC,
Gonçalves VM, et al. 2020. Cost analysis
based on bioreactor cultivation
conditions: Production of a soluble
27
Strategies for Enhancing Product Yield: Design of Experiments (DOE) for Escherichia coli…
DOI: http://dx.doi.org/10.5772/intechopen.99288
recombinant protein using Escherichia
coli BL21(DE3). Biotechnology Reports
26:e00441. DOI: https://doi.org/
10.1016/j.btre.2020.e00441.
[65] Siegele DA, Hu JC. 1997. Gene
expression from plasmids containing
the <em>araBAD</em> promoter at
subsaturating inducer concentrations
represents mixedpopulations.
Proceedings of the National Academy of
Sciences 94 (15):8168-8172. DOI:
10.1073/pnas.94.15.8168.
[66] Choi YJ, Morel L, Le François T,
Bourque D, Bourget L, Groleau D, et al.
2010. Novel, versatile, and tightly
regulated expression system for
Escherichia coli strains. Applied and
environmental microbiology 76 (15):
5058-5066. DOI: 10.1128/AEM.00413-10.
[67]Mujacic M, Cooper KW, Baneyx F.
1999. Cold-inducible cloning vectors for
low-temperature protein expression in
Escherichia coli: application to the
production of a toxic and proteolytically








artificial neural network for lysine–
methionine biosynthesis by Pediococcus
pentosaceus RF-1. Biotechnology&
Biotechnological Equipment 31 (5):
935-947. DOI: 10.1080/
13102818.2017.1335177.
[69] Elbing KL, Brent R. 2019. Recipes and
Tools for Culture of Escherichia coli.
Current protocols inmolecular biology
125 (1):e83-e. DOI: 10.1002/cpmb.83.
[70] Zhang C, Chen X, Zou R, Zhou K,
Stephanopoulos G, Too H-P. 2013.
Combining Genotype Improvement and
Statistical Media Optimization for
Isoprenoid Production in E. coli. PLoS
One 8 (10):e75164. DOI: 10.1371/
journal.pone.0075164.
[71] Zhu LW, Wang CC, Liu RS, Li HM,
Wan DJ, Tang YJ. 2012. Actinobacillus
succinogenes ATCC 55618 fermentation
medium optimisation for the production
of succinic acid by response surface
methodology. J Biomed Biotechnol 2012:
626137. DOI: 10.1155/2012/626137.
[72] Riesenberg D, Schulz V,
Knorre WA, Pohl HD, Korz D,
Sanders EA, et al. 1991. High cell density
cultivation of Escherichia coli at
controlled specific growth rate. J
Biotechnol 20 (1):17-27. DOI: 10.1016/
0168-1656(91)90032-Q.
[73]Ghaly AE, Kamal M, Correia LR.
2005. Kinetic modelling of continuous
submerged fermentation of cheese whey
for single cell protein production.
Bioresour Technol 96 (10):1143-1152.
DOI: 10.1016/j.biortech.2004.09.027.
[74] Amro AA, Salem-Bekhit MM,
Alanazi FK. 2014. Plackett-Burman
randomisation method for Bacterial
Ghosts preparation form E. coli JM109.
Saudi Pharm J 22 (3):273-279. DOI:
10.1016/j.jsps.2013.06.002.
[75] Li H, van den Driesche S, Bunge F,
Yang B, VellekoopMJ. 2019. Optimisation
of on-chip bacterial culture conditions
using the Box-Behnken design response
surfacemethodology for faster drug
susceptibility screening. Talanta 194:
627-33. DOI: https://doi.org/10.1016/j.tala
nta.2018.10.048.
[76] Aggarwal A, Singh H. 2005.
Optimisation of machining techniques
— A retrospective and literature review.
Sadhana 30 (6):699-711. DOI: 10.1007/
BF02716704.
[77] Ranjbari J, Babaeipour V, Vahidi H,
MoghimiH,MofidMR,NamvaranMM,
et al. 2015. Enhanced Production of
Insulin-like Growth Factor I Protein in
Escherichia coli byOptimisation of Five
28
Fermentation - Processes, Benefits and Risks
Key Factors. Iran J PharmRes 14 (3):
907-917.
[78] Sriwidodo S, Subroto T, Maksum I,
Wathoni N, Rostinawati T, Ulya H, et al.
2019. Optimisation of secreted
recombinant human epidermal growth
factor production using pectate lyase B
from Escherichia coli BL21(DE3) by
central composite design and its
production in high cell density culture.
Journal of Pharmacy And Bioallied
Sciences 11 (8):562-566. DOI: 10.4103/
jpbs.JPBS_207_19.
[79] Rhee JI, Kang T-H. 2007. On-line
process monitoring and chemometric
modeling with 2D fluorescence spectra
obtained in recombinant E. coli
fermentations. Process Biochemistry 42
(7):1124-34. DOI: https://doi.org/
10.1016/j.procbio.2007.05.007.
[80] Tai M, Ly A, Leung I, Nayar G.
2015. Efficient high-throughput
biological process characterisation:
Definitive screening design with the
ambr250 bioreactor system. Biotechnol
Prog 31 (5):1388-1395. DOI: 10.1002/
btpr.2142.
[81] Feyzdar M, Vali AR, Babaeipour V.
2013. Identification and Optimisation of
Recombinant E. coli Fed-Batch
Fermentation Producing γ-Interferon
Protein. International Journal of
Chemical Reactor Engineering 11 (1):
123-134. DOI: doi:10.1515/ijcre-
2012-0081.
[82] Zhang C, Fan D, Shang La, Ma X,
Luo Ye, Xue W, et al. 2010.
Optimisation of Fermentation Process
for Human-like Collagen Production of
Recombinant Escherichia coli Using
Response Surface Methodology. Chinese
Journal of Chemical Engineering 18 (1):
137-42. DOI: https://doi.org/10.1016/
S1004-9541(08)60334-1.
[83] Aydar AY. 2018. Utilisation of
response surface methodology in
optimisation of extraction of plant
materials. Statistical approaches with
emphasis on design of experiments
applied to chemical processes:157-169.
[84]Desai KM, Survase SA, Saudagar PS,
Lele SS, Singhal RS. 2008. Comparison
of artificial neural network (ANN) and
response surface methodology (RSM) in
fermentation media optimisation: Case
study of fermentative production of
scleroglucan. Biochemical Engineering
Journal 41 (3):266-73. DOI: https://doi.
org/10.1016/j.bej.2008.05.009.
[85] Kubilius J, Schrimpf M, Kar K,
Hong H, Majaj NJ, Rajalingham R, et al.
2019. Brain-like object recognition with
high-performing shallow recurrent
ANNs. arXiv preprint arXiv:190906161.
[86]Mishra M, Srivastava M, editors. A
view of artificial neural network. 2014
International Conference on Advances
in Engineering & Technology Research
(ICAETR-2014); 2014: IEEE.
[87] Khan S, Bhakuni V, Praveen V,
Tewari R, Tripathi CKM, Gupta VD.
2011. Maximising the native
concentration and shelf life of protein: a
multiobjective optimisation to reduce
aggregation. Applied microbiology and
biotechnology 89 (1):99-108. DOI:
10.1007/s00253-010-2835-5.
[88] Beg AH, Islam MZ, editors.
Advantages and limitations of genetic
algorithms for clustering records. 2016
IEEE 11th Conference on Industrial
Electronics and Applications (ICIEA);
2016: IEEE.
[89] Lagarias JC, Poonen B, Wright MH.
2012. Convergence of the Restricted
Nelder–Mead Algorithm in Two
Dimensions. SIAM Journal on
Optimization 22 (2):501-532.
[90] Singer S,Nelder J. 2009.Nelder-mead
algorithm. Scholarpedia 4 (7):2928.
[91]Gupta PK, Mukherjee P, Dhawan S,
Pandey AK, Mazumdar S, Gaur D, et al.
29
Strategies for Enhancing Product Yield: Design of Experiments (DOE) for Escherichia coli…
DOI: http://dx.doi.org/10.5772/intechopen.99288
2014. Production and preclinical
evaluation of Plasmodium falciparum
MSP-119 and MSP-311 chimeric protein,
PfMSP-Fu24. Clinical and vaccine
immunology : CVI. DOI: 10.1128/
CVI.00179-14.
[92] Favre-Bulle O, Schouten T,
Kingma J, Witholt B. 1991.
Bioconversion of n-octane to octanoic
acid by a recombinant Escherichia coli
cultured in a two-liquid phase
bioreactor. Biotechnology (N Y) 9 (4):
367-371.
[93] Sabatie J, Speck D, Reymund J,
Hebert C, Caussin L, Weltin D, et al.
1991. Biotin formation by recombinant
strains of Escherichia coli: influence of
the host physiology. J Biotechnol 20 (1):
29-49.
[94]Wagner CR, Benkovic SJ. 1990. Site
directed mutagenesis: a tool for enzyme
mechanism dissection. Trends
Biotechnol 8 (9):263-270.
[95] Kane JF. 1995. Effects of rare codon
clusters on high-level expression of
heterologous proteins in Escherichia
coli. Curr Opin Biotechnol 6 (5):
494-500.
[96] Kurland C, Gallant J. 1996. Errors of
heterologous protein expression. Curr
Opin Biotechnol 7 (5):489-493.
[97] Roche ED, Sauer RT. 1999. SsrA-
mediated peptide tagging caused by rare
codons and tRNA scarcity. EMBO J 18
(16):4579-4589. DOI: 10.1093/emboj/
18.16.4579.
[98] Zahn K. 1996. Overexpression of an
mRNA dependent on rare codons
inhibits protein synthesis and
cell growth. J Bacteriol 178 (10):
2926-2933.
[99] Gouy M, Gautier C. 1982. Codon
usage in bacteria: correlation with gene
expressivity. Nucleic Acids Res 10 (22):
7055-7074.
[100] Zhang SP, Zubay G, Goldman E.
1991. Low-usage codons in Escherichia
coli, yeast, fruit fly and primates. Gene
105 (1):61-72.
[101] Prapunwattana P,
Sirawaraporn W, Yuthavong Y,
Santi DV. 1996. Chemical synthesis of
the Plasmodium falciparum
dihydrofolate reductase-thymidylate
synthase gene. Mol Biochem Parasitol 83
(1):93-106.
[102]Mazumdar S, Sachdeva S,
Chauhan VS, Yazdani SS. 2010.
Identification of cultivation condition to
produce correctly folded form of a
malaria vaccine based on Plasmodium
falciparum merozoite surface protein-1
in Escherichia coli. Bioprocess and
biosystems engineering 33 (6):719-730.
DOI: 10.1007/s00449-009-0394-x.
[103] Baca AM, Hol WG. 2000.
Overcoming codon bias: a method for
high-level overexpression of
Plasmodium and other AT-rich parasite
genes in Escherichia coli. Int J Parasitol
30 (2):113-118.
[104] Sano G, Morimatsu K, Horii T.
1994. Purification and characterisation
of dihydrofolate reductase of
Plasmodium falciparum expressed by a
synthetic gene in Escherichia coli. Mol
Biochem Parasitol 63 (2):265-273.
[105] Cinquin O, Christopherson RI,
Menz RI. 2001. A hybrid plasmid for
expression of toxic malarial proteins in
Escherichia coli. Mol Biochem Parasitol
117 (2):245-247.
[106] Lindenthal C, Klinkert MQ. 2002.
Identification and biochemical
characterisation of a protein
phosphatase 5 homologue from
Plasmodium falciparum. Mol Biochem
Parasitol 120 (2):257-268.
[107]Hoffman SL, Rogers WO,
Carucci DJ, Venter JC. 1998. From
genomics to vaccines: malaria as a model
30
Fermentation - Processes, Benefits and Risks
system. Nat Med 4 (12):1351-1353. DOI:
10.1038/3934.
[108] Ryan W, Parulekar SJ. 1991.
Recombinant protein synthesis and
plasmid instability in continuous
cultures of Escherichia coli JM103
harboring a high copy number plasmid.
Biotechnol Bioeng 37 (5):415-429. DOI:
10.1002/bit.260370504.
[109]Hellmuth K, Korz DJ, Sanders EA,
Deckwer WD. 1994. Effect of growth
rate on stability and gene expression of
recombinant plasmids during
continuous and high cell density
cultivation of Escherichia coli TG1. J
Biotechnol 32 (3):289-298.
[110]Gupta R, Sharma P, Vyas VV. 1995.
Effect of growth environment on the
stability of a recombinant shuttle
plasmid, pCPPS-31, in Escherichia coli. J
Biotechnol 41 (1):29-37.
31
Strategies for Enhancing Product Yield: Design of Experiments (DOE) for Escherichia coli…
DOI: http://dx.doi.org/10.5772/intechopen.99288
